A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)
Clinical trial NCT01467479 · TERMINATED
Trial details
- NCT number
- NCT01467479
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2014-02-01
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.